Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Zurletrectinib is a next-generation TRK inhibitor with st... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents
0
Authors
Paola Roa
21 more
Paola Roa
•
Valentina Foglizzo
19 more
•
Emiliano Cocco
Published
June 20, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Cancer
Topics
Biology
Biochemistry
Molecular Biology
Pathology And Forensic Medicine
Neurotrophin
Show all topics
DOI
10.1038/s41416-024-02760-1
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
British Journal of Cancer
Topics
Biology
Biochemistry
Molecular Biology
Pathology And Forensic Medicine
Neurotrophin
Show all topics
DOI
10.1038/s41416-024-02760-1
License
CC-BY
Other Formats
PDF
